drugset / Trial / NCT04975698
HIV Antigen-specific T-cells Targeting Conserved Epitopes (HST-NEETs) BMTCTN1903
Phase 2
Completed
12 enrolled
Catherine Bollard
Blood and Marrow Transplant Clinical Trials Network · collabChildren's National Research Institute · collabNational Cancer Institute (NCI) · collabNational Heart, Lung, and Blood Institute (NHLBI) · collabNational Marrow Donor Program · collab
NaSingle-groupOpen-labelTreatment
Summary
This is a Phase II multi-center trial single arm trial of autologous transplantation (ASCT) followed by administration of HST-NEETs for treatment of HIV associated lymphoma
Timeline
- Start
- 2021-10-25
- Primary completion
- 2025-11-24
- Completion
- 2026-01-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | HST-NEETs | Cell therapy | 2e+07 unknown | Intravenous |